Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
We evaluate ETFs that minimize taxes on retirement income, aiming to boost net returns while controlling tax impact on withdrawals.
23,314 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Target rolls out a broad turnaround, including redesigned carts and a baby concierge service, but investors question ...
Sea Limited blends e-commerce, gaming, and fintech in Southeast Asia. This article explores whether its stock is a li...
Markets are buzzing about a downturn, but the latest data suggests reacting to headlines may hurt more than help. Thi...
Is Micron Technology stock on a durable uptrend or chasing a bubble? This guide lays out the signals, scenarios, and ...
Two very different paths define the nuclear renaissance: NuScale's small modular reactors and BWX Technologies' broad...
May data show rising inflation pressures even as growth slows, with renewed Middle East tensions fanning fears of sta...
When a major hedge fund trims a stake in a diversified telecom, it sends a message to the market. This article breaks...
Regulators and crypto firms clash as debates over national bank charters intensify. This article breaks down what’s a...
Oregon's push to shift recycling costs to manufacturers promised cleaner streets and better recycling, but the rollou...
A sharp move lower has investors asking if the lululemon stock just 52-week headlines reflect a durable change or a t...
Oil benchmarks jumped after a new round of U.S.-Iran strikes raised supply concerns and threatened to derail fragile ...